Victoria Anne Parker

Victoria Anne Parker

Auto-generated profile, based on publicly available information

Victoria Anne Parker

Boston University School of Public Health, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in Health Affairs
Verified
Journal Article
Closed access
PDF file
MSMegan Sandel
Megan Sandel
MHMark Hansen
Mark Hansen
RKRobert Kahn
Robert Kahn
ELEllen Lawton
Ellen Lawton
EPEdward Paul
Edward Paul
BZBarry Zuckerman
Barry Zuckerman
Health care is undermined when patients don’t receive the benefit of laws intended to address social determinants of health, such as housing and food. Medical-legal partnerships, which now exist in more than 200 clinical sites in the United States, integrate lawyers into health care to address legal problems that create and perpetuate poor health. This paper describes how such medical-legal partnerships can change clinical systems—for example, by adding legal form letters to electronic health records to help low-income patients rectify substandard housing conditions. We recommend the integration of medical-legal partnerships into federal health care programs.

1 September 2017 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
JLJane M. Liebschutz
Jane M. Liebschutz
ZXZiming Xuan
Ziming Xuan
CSChristopher W. Shanahan
Christopher W. Shanahan
MLMarc LaRochelle
Marc LaRochelle
JKJulia Keosaian
Julia Keosaian
KLKaren E. Lasser
Karen E. Lasser
The United States is facing an opioid morbidity and mortality crisis.1 Legitimately prescribed opioid analgesics contribute to the availability of opioids, and they are then used for nonmedical purposes.2 Quiz Ref ID To improve opioid prescribing, professional medical societies and the Centers for Disease Control and Prevention have released clinical guidelines for long-term opioid therapy.3-6 These guidelines call for use of patient-clinician agreements (agreements), urine drug testing (UDT), prescription drug monitoring programs (PDMPs), and assessment tools to mitigate risks of long-term opioid therapy.3 In addition, the guidelines recommend against prescribing high-dose opioids (eg, ≥100 mg morphine-equivalent daily dose [MEDD]).4 National approaches to improve opioid prescribing include voluntary continuing medical education for prescribers,5,6 mandatory online education courses,7 state regulatory interventions8 (eg, mandatory use of PDMPs),9-12 and limitations on insurance coverage for opioid analgesic prescriptions based on duration or dose.13-15

28 June 2004 in Archives of internal medicine (1960)
Verified
Journal Article
Closed access
PDF file
SFSusan M. Frayne
Susan M. Frayne
MSMargaret R. Seaver
Margaret R. Seaver
SLSusan Loveland
Susan Loveland
CCCindy L. Christiansen
Cindy L. Christiansen
Avron SpiroAvron Spiro
Avron Spiro
KSKatherine M. Skinner
Katherine M. Skinner
Research from JAMA Internal Medicine — Burden of Medical Illness in Women With Depression and Posttraumatic Stress Disorder

1 April 2012 in Advances in Skin & Wound Care
Verified
Journal Article
Closed access
ANAndrea Niederhauser
Andrea Niederhauser
CLCarol VanDeusen Lukas
Carol VanDeusen Lukas
VPVictoria Parker
Victoria Parker
EAElizabeth A. Ayello
Elizabeth A. Ayello
KZKaren Zulkowski
Karen Zulkowski
DBDan Berlowitz
Dan Berlowitz
The objective of this study was to examine the evidence supporting the combined use of interventions to prevent pressure ulcers (PrUs) in acute care and long-term-care facilities. A systematic review of the literature describing multifaceted PrU prevention programs was performed. Articles were included if they described an intervention implemented in acute care settings or long-term-care facilities, incorporated more than 1 intervention component, involved a multidisciplinary team, and included information about outcomes related to the intervention. Twenty-four studies were identified. Recurring components used in the development and implementation of PrU prevention programs included preparations prior to the start of a program, PrU prevention best practices, staff education, clinical monitoring and feedback, skin care champions, and cues to action. Ten studies reported PrU prevalence rates; 9 of them reported decreased prevalence rates at the end of their programs. Of the 6 studies reporting PrU incidence rates, 5 reported a decrease in incidence rates. Four studies measured care processes: 1 study reported an overall improvement; 2 studies reported improvement on some, but not all, measures; and 1 study reported no change. There is a growing literature describing multipronged, multidisciplinary interventions to prevent PrUs in acute care settings and long-term-care facilities. Outcomes reported in these studies suggest that such programs can be successful in reducing PrU prevalence or incidence rates. However, to strengthen the level of evidence, sites should be encouraged to rigorously evaluate their programs and to publish their results.

1 March 2006 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
SFSusan M. Frayne
Susan M. Frayne
VPVictoria A. Parker
Victoria A. Parker
CCCindy L. Christiansen
Cindy L. Christiansen
SLSusan Loveland
Susan Loveland
MSMargaret R. Seaver
Margaret R. Seaver
KSKatherine M. Skinner
Katherine M. Skinner

8 March 2010 in Health Services Research
Verified
Journal Article
Closed access
PDF file
VPVictoria A. Parker
Victoria A. Parker
JCJack A. Clark
Jack A. Clark
JLJenniffer Leyson
Jenniffer Leyson
ECElizabeth Calhoun
Elizabeth Calhoun
JCJennifer K. Carroll
Jennifer K. Carroll
TBTracy A. Battaglia
Tracy A. Battaglia